(+)-VINCRISTINE
Colorectal Cancer Metastatic
Oncolytics BiotechSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 58/ 100
- Competitive Position
- 65/ 100
Competitive context
89 Active assets in the Colorectal Cancer Metastatic cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Ciusss de L'Est de l'Île de Montréal | Phase 4 | BB |
Calcium folinate pentahydrate Ciusss de L'Est de l'Île de Montréal | Phase 4 | BB |
Irinotecan Oncolytics Biotech | Phase 4 | BB |
Aflibercept Sanofi | Phase 3 | BB |
Regorafenib China Medical University, China | Phase 4 | BB |
View all 50 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →